Overview
Hao Zhou practices in Shanghai, China. Mr. Zhou is rated as an Experienced expert by MediFind in the treatment of Pyruvate Dehydrogenase Deficiency. His top areas of expertise are Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Coronary Heart Disease, Pyruvate Decarboxylase Deficiency, and Percutaneous Coronary Intervention (PCI).
His clinical research consists of co-authoring 128 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pyruvate Dehydrogenase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cardiomyopathy Due to Anthracyclines
- Doxorubicin-Induced Cardiomyopathy
- Experienced
- Acute Coronary SyndromeMr. Zhou isExperienced. Learn about Acute Coronary Syndrome.
- Atrial FibrillationMr. Zhou isExperienced. Learn about Atrial Fibrillation.
- CardiomyopathyMr. Zhou isExperienced. Learn about Cardiomyopathy.
- Coronary Heart DiseaseMr. Zhou isExperienced. Learn about Coronary Heart Disease.
- Heart AttackMr. Zhou isExperienced. Learn about Heart Attack.
- Heart FailureMr. Zhou isExperienced. Learn about Heart Failure.